Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: A randomised, double-blind, placebo-controlled, dose-escalation trial Academic Article Article uri icon

Overview

MeSH Major

  • Anxiety
  • Depression
  • Thalassemia

abstract

  • ICL670 given once daily at 20 mg/kg seems to be an effective orally active iron chelator and is reasonably well tolerated. Long-term studies are now necessary to establish the practical contribution of this drug.

publication date

  • May 10, 2003

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/S0140-6736(03)13309-0

PubMed ID

  • 12747879

Additional Document Info

start page

  • 1597

end page

  • 602

volume

  • 361

number

  • 9369